ALHEMO J Code: J7173

Drug & Product Overview

HCPCS Descriptor Injection, concizumab-mtci, 0.5 mg

HCPCS Added Date October 1, 2025

Manufacturer Novo Nordisk

Route of Administration Subcutaneous

Generic Status Single-Source; Branded

Dosage Form Injection, Solution

About ALHEMO

Alhemo is a medication aligned to the HCPCS J Code: J7173 for billing, pricing, and reimbursement purposes in the United States. This Hematology medication is administered via the subcutaneous route and manufactured by Novo Nordisk.

According to CMS Drug Use Information: This medication is used by people with a certain inherited bleeding problem (hemophilia A or B) to help prevent or lessen how often you have bleeding problems. Concizumab belongs to a class of medications known as monoclonal antibodies. It works by helping your blood to clot normally, which helps prevent bleeding due to hemophilia.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
00169-2080-15	Alhemo	Novo Nordisk	300	150 MG / 1.5 ML
00169-2081-03	Alhemo	Novo Nordisk	600	300 MG / 3 ML
00169-2084-15	Alhemo	Novo Nordisk	120	60 MG / 1.5 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

ALHEMO Pricing & Reimbursement

J7173 Private Payer Reimbursement

$85.60 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

ALHEMO CPT Administration Codes

CPT Code	Description
96372	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular

Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

ALHEMO Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

hemophilia A with or without FVIII inhibitors hemophilia B with or without FIX inhibitors

Drug Class

Tissue Factor Pathway Inhibitor Antagonist [EPC]Tissue Factor Pathway Inhibitor Antagonists [MoA]

Frequently Asked Questions

Is there an available Alhemo billing and coding guide?

Billing and coding information for ALHEMO can be found through Novo Nordisk. Visit Here →

Are there any available Alhemo patient assistance programs?

ALHEMO patient assistance information can be found through Novo Nordisk, Inc.. Visit Here →

Where can I find Alhemo prescribing information?

Alhemo prescribing information can be found through the link below. Visit Here →

Where can I find Alhemo side effect information?

Alhemo side effect information can be found at the link below. Visit Here →

Does billing Alhemo require wastage modifiers?

CMS does not include ALHEMO (J7173) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J7173. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.